Learn About Dr. Sahab Yaqubi
I am board-certified in both psychiatry and psychosomatic medicine, with a specialized focus on Mood and Anxiety disorders. I employ a collaborative and holistic approach to develop personalized treatment plan for each patient. I value my patients’ questions as they open the door to dialogue and a deeper understanding, allowing us to determine the best treatment for each individual. I have found that understanding and empathizing with my patients' emotional pain is crucial for developing a strong therapeutic rapport.
Depression and Anxiety can severely impact our ability to connect with others, often leaving us feeling isolated. At our practice, we work closely with patients, finding a right path to help them reconnect with themselves and their loved ones.
Psychotherapy and Medication Management are the first lines of treatment for depression and anxiety. I also work with patients with treatment resistant depression and anxiety. I find Ketamine and Transcranial Magnetic Stimulation (TMS) a non-invasive therapeutic tool that can play a crucial role for those with treatment-resistant mood and anxiety.
-
Dr. Yaqubi received his medical degree from Shahid Beheshti University of Medical Sciences (SBMU) in Tehran, Iran. To pursue his academic career, he moved to the United States and completed a Postdoctoral Research Fellowship in the Department of Genetics & Genomics at Boston University School of Medicine, where his research focused on the epigenetic dysregulation in patients with bipolar disorder and schizophrenia.
He then completed his Psychiatry Residency, followed by a Fellowship in Psychosomatic Medicine/Consultation-Liaison at the Icahn School of Medicine at Mount Sinai in New York City. During his fellowship, he specialized in Transplant Psychiatry, Psycho-oncology, and Neuropsychiatry. Afterward, Dr. Yaqubi worked at the Recanati/Miller Transplant Institute at Mount Sinai Hospital, where he served as an Assistant Professor of Psychiatry, teaching and supervising medical students, residents, and fellows. Dr. Yaqubi continued working as an Assistant Clinical Professor of Psychiatry at the Icahn School of Medicine/Beth Israel Hospital in the Comprehensive Psychiatric Emergency Program, leading a multidisciplinary team that included residents, nurses, and social workers.
He relocated to California and been focusing on treatment of patients with treatment resistant depression and anxiety at Mindful Health Solutions, a large interventional psychiatric practice in California.
-
Board certified, American Board of Psychiatry and Neurology
Board Certified, American Board of Psychosomatic Medicine/ Consultation-Liaison Psychiatry
Member, American Psychiatric Association
Member, Clinical TMS Society
-
James W. Murrough, Sahab Yaqubi, Sehrish Sayed and Dennis S. Charney. “Emerging Drugs for the Treatment of Anxiety”. Expert Opin Emerg Drugs 2015 May 26:1-14. Cited in PubMed; PMID: 26012843
Hamid M Abdolmaleky, Sahab Yaqubi, Panos Papageorgis, Arthur W. Lambert, Sait Ozturk, Vadivelu Sivaraman and Sam Thiagalingam. “Epigenetic dysregulation of HTR2A in the Brain of patients with schizophrenia and bipolar disorder”. Schizophrenia Research 129 (2011) pp. 183-190. Cited in PubMed; PMID: 21550210
Rahim Shafa, Hamid Abdolmaleky, Sahab Yaqubi, Casandra L Smith, Nassir Ghaemi. Entacapone as an Anti-Craving Treatment in Substance Abuse and Dependence. The American Journal on Addictions 17(4), pp. 331-332, 2008